Canadian Respiratory Journal

Canadian Respiratory Journal / 2003 / Article

Guidelines | Open Access

Volume 10 |Article ID 486285 | https://doi.org/10.1155/2003/486285

Meyer S Balter, Jacques La Forge, Donald E Low, Lionel Mandell, Ronald F Grossman, the Chronic Bronchitis Working Group, "Canadian Guidelines for the Management of Acute Exacerbations of Chronic Bronchitis", Canadian Respiratory Journal, vol. 10, Article ID 486285, 30 pages, 2003. https://doi.org/10.1155/2003/486285

Canadian Guidelines for the Management of Acute Exacerbations of Chronic Bronchitis

Abstract

Acute exacerbations of chronic bronchitis (AECB) account for over 1.5 million physician visits annually in Canada and are a cause of significant morbidity and mortality. This document represents a joint effort between respirologists, microbiologists, infectious disease specialists and family physicians to update the Canadian AECB guidelines published in 1994. Treatment recommendations are graded on the strength of evidence in the published literature where possible. The role for oral corticosteroid therapy in preventing treatment failures, speeding up recovery and delaying the time to next exacerbation is discussed. Risk factors for treatment failure were used to stratify patients into risk groups to help guide antibiotic treatment recommendations. The importance of emerging antimicrobial resistance to current antibiotics is reviewed and strategies to prevent future AECB episodes are suggested.

Copyright © 2003 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

 PDF Download Citation Citation
 Order printed copiesOrder
Views267
Downloads1227
Citations

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.